메뉴 건너뛰기




Volumn 12, Issue 3, 2012, Pages 219-228

Application of classic utilities to published pediatric cost-utility studies

Author keywords

child; cost benefit analysis; cost effectiveness; cost utility analysis; quality adjusted life years; utility

Indexed keywords

ASTHMA; ATTENTION DEFICIT DISORDER; CHILD; CHILD HEALTH CARE; COCHRANE LIBRARY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; CUSTODY; DATA EXTRACTION; DRUG INDUSTRY; EDUCATIONAL STATUS; EMBASE; ETHNICITY; GASTROENTERITIS; HEARING LOSS; HUMAN; INCOME; INFORMATION RETRIEVAL; INTERVIEW; LIFE EXPECTANCY; MEDLINE; MENTAL DEFICIENCY; NURSE; OTITIS MEDIA; PATIENT PREFERENCE; POPULATION; QUALITY ADJUSTED LIFE YEAR; RACE; RATING SCALE; REVIEW; SEIZURE; SENSITIVITY ANALYSIS; UNIVERSITY HOSPITAL; VISUAL ANALOG SCALE; VISUAL IMPAIRMENT;

EID: 84861168845     PISSN: 18762859     EISSN: 18762867     Source Type: Journal    
DOI: 10.1016/j.acap.2011.09.003     Document Type: Article
Times cited : (8)

References (59)
  • 1
    • 1642580634 scopus 로고    scopus 로고
    • Trends in paediatric health economic evaluation: 1980 to 1999
    • W.J. Ungar, and M.T. Santos Trends in paediatric health economic evaluation: 1980 to 1999 Arch Dis Child 89 2004 26 29
    • (2004) Arch Dis Child , vol.89 , pp. 26-29
    • Ungar, W.J.1    Santos, M.T.2
  • 2
    • 25144481018 scopus 로고    scopus 로고
    • Quality-adjusted life-years lack quality in pediatric care: A critical review of published cost-utility studies in child health
    • I. Griebsch, J. Coast, and J. Brown Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health Pediatrics 115 2005 e600 e614
    • (2005) Pediatrics , vol.115
    • Griebsch, I.1    Coast, J.2    Brown, J.3
  • 4
    • 0029794708 scopus 로고    scopus 로고
    • Recommendations of the panel on cost-effectiveness in health and medicine
    • M.C. Weinstein, J.E. Siegel, and M.R. Gold Recommendations of the panel on cost-effectiveness in health and medicine JAMA 276 1996 1253 1258
    • (1996) JAMA , vol.276 , pp. 1253-1258
    • Weinstein, M.C.1    Siegel, J.E.2    Gold, M.R.3
  • 8
    • 0037353837 scopus 로고    scopus 로고
    • Health care economic analyses and value-based medicine
    • M.M. Brown, G.C. Brown, and S. Sharma Health care economic analyses and value-based medicine Surv Ophthalmol 48 2003 204 223
    • (2003) Surv Ophthalmol , vol.48 , pp. 204-223
    • Brown, M.M.1    Brown, G.C.2    Sharma, S.3
  • 9
    • 0023224082 scopus 로고
    • Utility approach to measuring health-related quality of life
    • G.W. Torrance Utility approach to measuring health-related quality of life J Chronic Dis 40 1987 593 603
    • (1987) J Chronic Dis , vol.40 , pp. 593-603
    • Torrance, G.W.1
  • 11
    • 0042528209 scopus 로고    scopus 로고
    • Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public
    • P.A. Ubel, G. Loewenstein, and C. Jepson Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public Qual Life Res 12 2003 599 607
    • (2003) Qual Life Res , vol.12 , pp. 599-607
    • Ubel, P.A.1    Loewenstein, G.2    Jepson, C.3
  • 12
    • 77953710259 scopus 로고    scopus 로고
    • QALY weights for neurosensory impairments in pediatric economic evaluations: Case studies and a critique
    • S. Grosse, L. Prosser, and K. Asakawa QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique Expert Rev Pharmacoecon Outcomes Res 10 2010 293 308
    • (2010) Expert Rev Pharmacoecon Outcomes Res , vol.10 , pp. 293-308
    • Grosse, S.1    Prosser, L.2    Asakawa, K.3
  • 13
    • 67649238813 scopus 로고    scopus 로고
    • Estimating preference-based health utilities index mark 3 utility scores for childhood conditions in England and Scotland
    • S. Petrou, and E. Kupek Estimating preference-based health utilities index mark 3 utility scores for childhood conditions in England and Scotland Med Decis Making 29 2009 291 303
    • (2009) Med Decis Making , vol.29 , pp. 291-303
    • Petrou, S.1    Kupek, E.2
  • 14
    • 67649794702 scopus 로고    scopus 로고
    • Improving decision analyses: Parent preferences (utility values) for pediatric health outcomes
    • e1-5
    • A.E. Carroll, and S.M. Downs Improving decision analyses: parent preferences (utility values) for pediatric health outcomes J Pediatr 155 2009 21 25 e1-5
    • (2009) J Pediatr , vol.155 , pp. 21-25
    • Carroll, A.E.1    Downs, S.M.2
  • 15
    • 0021021373 scopus 로고
    • The Markov process in medical prognosis
    • J.R. Beck, and S.G. Pauker The Markov process in medical prognosis Med Decis Making 3 1983 419 458
    • (1983) Med Decis Making , vol.3 , pp. 419-458
    • Beck, J.R.1    Pauker, S.G.2
  • 16
    • 66249084557 scopus 로고    scopus 로고
    • New vaccines against otitis media: Projected benefits and cost-effectiveness
    • M.A. O'Brien, L.A. Prosser, and J.L. Paradise New vaccines against otitis media: projected benefits and cost-effectiveness Pediatrics 123 2009 1452 1463
    • (2009) Pediatrics , vol.123 , pp. 1452-1463
    • O'Brien, M.A.1    Prosser, L.A.2    Paradise, J.L.3
  • 17
    • 0028649511 scopus 로고
    • An economic analysis of alternatives for childhood immunisation against Haemophilus influenzae type b disease
    • P. McIntyre, J. Hall, and S. Leeder An economic analysis of alternatives for childhood immunisation against Haemophilus influenzae type b disease Aust J Public Health 18 1994 394 400
    • (1994) Aust J Public Health , vol.18 , pp. 394-400
    • McIntyre, P.1    Hall, J.2    Leeder, S.3
  • 18
    • 0242317694 scopus 로고    scopus 로고
    • Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada
    • P. De Wals, G. Petit, and L.J. Erickson Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada Vaccine 21 2003 3757 3764
    • (2003) Vaccine , vol.21 , pp. 3757-3764
    • De Wals, P.1    Petit, G.2    Erickson, L.J.3
  • 19
    • 0037866947 scopus 로고    scopus 로고
    • Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland
    • S.M. Ess, U.B. Schaad, and A. Gervaix Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland Vaccine 21 2003 3273 3281
    • (2003) Vaccine , vol.21 , pp. 3273-3281
    • Ess, S.M.1    Schaad, U.B.2    Gervaix, A.3
  • 20
    • 0027522312 scopus 로고
    • Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity
    • J. Javitt, R. Dei Cas, and Y.P. Chiang Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity Pediatrics 91 1993 859 866
    • (1993) Pediatrics , vol.91 , pp. 859-866
    • Javitt, J.1    Dei Cas, R.2    Chiang, Y.P.3
  • 22
    • 0023801539 scopus 로고
    • Economic aspects of cataract
    • M.F. Drummond Economic aspects of cataract Ophthalmology 95 1988 1147 1153
    • (1988) Ophthalmology , vol.95 , pp. 1147-1153
    • Drummond, M.F.1
  • 24
    • 35548971236 scopus 로고    scopus 로고
    • Modeling the impact of genetic screening technologies on healthcare: Theoretical model for asthma in children
    • E. Gutierrez de Mesa, I. Hidalgo, and P. Christidis Modeling the impact of genetic screening technologies on healthcare: theoretical model for asthma in children Mol Diagn Ther 11 2007 313 323
    • (2007) Mol Diagn Ther , vol.11 , pp. 313-323
    • Gutierrez De Mesa, E.1    Hidalgo, I.2    Christidis, P.3
  • 25
    • 74049116642 scopus 로고    scopus 로고
    • Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: A Canadian prospective study
    • M. Brisson, M. Sénécal, and M. Drolet Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study Pediatr Infect Dis J 29 2010 73 75
    • (2010) Pediatr Infect Dis J , vol.29 , pp. 73-75
    • Brisson, M.1    Sénécal, M.2    Drolet, M.3
  • 26
    • 0036791142 scopus 로고    scopus 로고
    • Impact of universal haemophilus influenzae type b vaccination starting at 2 months of age in the United States: An economic analysis
    • F. Zhou, K.M. Bisgard, and H.R. Yusuf Impact of universal haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis Pediatrics 110 2002 653 661
    • (2002) Pediatrics , vol.110 , pp. 653-661
    • Zhou, F.1    Bisgard, K.M.2    Yusuf, H.R.3
  • 27
    • 0242509086 scopus 로고    scopus 로고
    • Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands
    • J.M. Bos, H. Rumke, and R. Welte Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands Clin Ther 25 2003 2614 2630
    • (2003) Clin Ther , vol.25 , pp. 2614-2630
    • Bos, J.M.1    Rumke, H.2    Welte, R.3
  • 28
    • 0034675046 scopus 로고    scopus 로고
    • Cost-utility analysis of the cochlear implant in children
    • A.K. Cheng, H.R. Rubin, and N.R. Powe Cost-utility analysis of the cochlear implant in children JAMA 284 2000 850 856
    • (2000) JAMA , vol.284 , pp. 850-856
    • Cheng, A.K.1    Rubin, H.R.2    Powe, N.R.3
  • 29
    • 11144357017 scopus 로고    scopus 로고
    • Cost effectiveness of treatment for amblyopia: An analysis based on a probabilistic Markov model
    • H.H. Konig, and J.C. Barry Cost effectiveness of treatment for amblyopia: an analysis based on a probabilistic Markov model Br J Ophthalmol 88 2004 606 612
    • (2004) Br J Ophthalmol , vol.88 , pp. 606-612
    • Konig, H.H.1    Barry, J.C.2
  • 30
    • 48349106204 scopus 로고    scopus 로고
    • The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: A systematic review and economic evaluation
    • iii, xi-194
    • J. Carlton, J. Karnon, and C. Czoski-Murray The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation Health Technol Assess 12 2008 iii, xi-194
    • (2008) Health Technol Assess , vol.12
    • Carlton, J.1    Karnon, J.2    Czoski-Murray, C.3
  • 31
    • 33846695153 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of treatment options for acute otitis media
    • A.S. Coco Cost-effectiveness analysis of treatment options for acute otitis media Ann Fam Med 5 2007 29 38
    • (2007) Ann Fam Med , vol.5 , pp. 29-38
    • Coco, A.S.1
  • 32
    • 65449173644 scopus 로고    scopus 로고
    • A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
    • J. Hong, T. Dilla, and J. Arellano A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain BMC Psychiatry 9 2009 15
    • (2009) BMC Psychiatry , vol.9 , pp. 15
    • Hong, J.1    Dilla, T.2    Arellano, J.3
  • 33
    • 39149083447 scopus 로고    scopus 로고
    • The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands
    • L.M. Goossens, B. Standaert, and N. Hartwig The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands Vaccine 26 2008 1118 1127
    • (2008) Vaccine , vol.26 , pp. 1118-1127
    • Goossens, L.M.1    Standaert, B.2    Hartwig, N.3
  • 34
    • 65349102876 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France
    • B. Standaert, N. Parez, and B. Tehard Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France Appl Health Econ Health Policy 6 2008 199 216
    • (2008) Appl Health Econ Health Policy , vol.6 , pp. 199-216
    • Standaert, B.1    Parez, N.2    Tehard, B.3
  • 35
    • 0036897110 scopus 로고    scopus 로고
    • A cost-utility analysis of therapy for amblyopia
    • J.H. Membreno, M.M. Brown, and G.C. Brown A cost-utility analysis of therapy for amblyopia Ophthalmology 109 2002 2265 2271
    • (2002) Ophthalmology , vol.109 , pp. 2265-2271
    • Membreno, J.H.1    Brown, M.M.2    Brown, G.C.3
  • 37
    • 33748521891 scopus 로고    scopus 로고
    • Hearing-impaired children in the United Kingdom, IV: Cost-effectiveness of pediatric cochlear implantation
    • G.R. Barton, P.C. Stacey, and H.M. Fortnum Hearing-impaired children in the United Kingdom, IV: cost-effectiveness of pediatric cochlear implantation Ear Hear 27 2006 575 588
    • (2006) Ear Hear , vol.27 , pp. 575-588
    • Barton, G.R.1    Stacey, P.C.2    Fortnum, H.M.3
  • 38
    • 67649359305 scopus 로고    scopus 로고
    • Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK
    • A. Martin, A. Batty, and J.A. Roberts Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK Vaccine 27 2009 4520 4528
    • (2009) Vaccine , vol.27 , pp. 4520-4528
    • Martin, A.1    Batty, A.2    Roberts, J.A.3
  • 40
    • 0033209806 scopus 로고    scopus 로고
    • Cost-effectiveness of treatment for threshold retinopathy of prematurity
    • G.C. Brown, M.M. Brown, and S. Sharma Cost-effectiveness of treatment for threshold retinopathy of prematurity Pediatrics 104 1999 e47
    • (1999) Pediatrics , vol.104 , pp. 47
    • Brown, G.C.1    Brown, M.M.2    Sharma, S.3
  • 41
    • 65249169460 scopus 로고    scopus 로고
    • Cost-utility analysis of screening and laser treatment of retinopathy of prematurity
    • J. Dunbar, V. Hsu, and M. Christensen Cost-utility analysis of screening and laser treatment of retinopathy of prematurity J AAPOS 13 2009 186 190
    • (2009) J AAPOS , vol.13 , pp. 186-190
    • Dunbar, J.1    Hsu, V.2    Christensen, M.3
  • 42
    • 33748278913 scopus 로고    scopus 로고
    • A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents
    • iii-iv, xiii-146
    • S. King, S. Griffin, and Z. Hodges A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents Health Technol Assess 10 2006 iii-iv, xiii-146
    • (2006) Health Technol Assess , vol.10
    • King, S.1    Griffin, S.2    Hodges, Z.3
  • 43
    • 59549085888 scopus 로고    scopus 로고
    • Cost-effectiveness of rotavirus vaccination: Exploring caregiver(s) and "no medical care" disease impact in Belgium
    • J. Bilcke, P. Van Damme, and P. Beutels Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care" disease impact in Belgium Med Decis Making 29 2009 33 50
    • (2009) Med Decis Making , vol.29 , pp. 33-50
    • Bilcke, J.1    Van Damme, P.2    Beutels, P.3
  • 44
    • 66249115943 scopus 로고    scopus 로고
    • Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel
    • G. Chodick, O. Waisbourd-Zinman, and V. Shalev Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel Eur J Public Health 19 2009 254 259
    • (2009) Eur J Public Health , vol.19 , pp. 254-259
    • Chodick, G.1    Waisbourd-Zinman, O.2    Shalev, V.3
  • 45
    • 34247250150 scopus 로고    scopus 로고
    • Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination
    • M. Jit, and W.J. Edmunds Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination Vaccine 25 2007 3971 3979
    • (2007) Vaccine , vol.25 , pp. 3971-3979
    • Jit, M.1    Edmunds, W.J.2
  • 46
    • 67651229443 scopus 로고    scopus 로고
    • Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule
    • R.J. Milne, and K. Grimwood Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule Value Health 12 2009 888 898
    • (2009) Value Health , vol.12 , pp. 888-898
    • Milne, R.J.1    Grimwood, K.2
  • 47
    • 36549037619 scopus 로고    scopus 로고
    • The cost-effectiveness of rotavirus vaccination in Australia
    • A.T. Newall, P. Beutels, and K. Macartney The cost-effectiveness of rotavirus vaccination in Australia Vaccine 25 2007 8851 8860
    • (2007) Vaccine , vol.25 , pp. 8851-8860
    • Newall, A.T.1    Beutels, P.2    MacArtney, K.3
  • 48
    • 1442332048 scopus 로고    scopus 로고
    • Cost-utility analysis of orthoptic screening in kindergarten: A Markov model based on data from Germany
    • H.H. Konig, and J.C. Barry Cost-utility analysis of orthoptic screening in kindergarten: a Markov model based on data from Germany Pediatrics 113 2004 e95 e108
    • (2004) Pediatrics , vol.113
    • Konig, H.H.1    Barry, J.C.2
  • 49
    • 67650725906 scopus 로고    scopus 로고
    • Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK
    • S. Prasad, J. Arellano, and C. Steer Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK Int J Clin Pract 63 2009 1031 1040
    • (2009) Int J Clin Pract , vol.63 , pp. 1031-1040
    • Prasad, S.1    Arellano, J.2    Steer, C.3
  • 50
    • 0034960256 scopus 로고    scopus 로고
    • Methylphenidate in children with hyperactivity: Review and cost-utility analysis
    • A. Gilmore, and R. Milne Methylphenidate in children with hyperactivity: review and cost-utility analysis Pharmacoepidemiol Drug Saf 10 2001 85 94
    • (2001) Pharmacoepidemiol Drug Saf , vol.10 , pp. 85-94
    • Gilmore, A.1    Milne, R.2
  • 51
    • 38149076421 scopus 로고    scopus 로고
    • Long-acting methylphenidate-OROS in youths with attention-deficit hyperactivity disorder suboptimally controlled with immediate-release methylphenidate: A study of cost effectiveness in the Netherlands
    • A. Faber, M. van Agthoven, and L.J. Kalverdijk Long-acting methylphenidate-OROS in youths with attention-deficit hyperactivity disorder suboptimally controlled with immediate-release methylphenidate: a study of cost effectiveness in The Netherlands CNS Drugs 22 2008 157 170
    • (2008) CNS Drugs , vol.22 , pp. 157-170
    • Faber, A.1    Van Agthoven, M.2    Kalverdijk, L.J.3
  • 52
    • 0035815564 scopus 로고    scopus 로고
    • Indirect costs, cost-utility variations and the funding of paediatric cochlear implantation
    • C. O'Neill, S.M. Archbold, and G.M. O'Donoghue Indirect costs, cost-utility variations and the funding of paediatric cochlear implantation Int J Pediatr Otorhinolaryngol 58 2001 53 57
    • (2001) Int J Pediatr Otorhinolaryngol , vol.58 , pp. 53-57
    • O'Neill, C.1    Archbold, S.M.2    O'Donoghue, G.M.3
  • 53
    • 34249846809 scopus 로고    scopus 로고
    • Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy
    • G. de Lissovoy, L.S. Matza, and H. Green Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy J Child Neurol 22 2007 49 59
    • (2007) J Child Neurol , vol.22 , pp. 49-59
    • De Lissovoy, G.1    Matza, L.S.2    Green, H.3
  • 54
    • 43949111998 scopus 로고    scopus 로고
    • Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: A cost-effectiveness analysis
    • M.A. Hoving, S.M. Evers, and A.J. Ament Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a cost-effectiveness analysis Dev Med Child Neurol 50 2008 450 455
    • (2008) Dev Med Child Neurol , vol.50 , pp. 450-455
    • Hoving, M.A.1    Evers, S.M.2    Ament, A.J.3
  • 55
    • 55949087185 scopus 로고    scopus 로고
    • The long-term cost-effectiveness of fetal monitoring during labour: A comparison of cardiotocography complemented with ST analysis versus cardiotocography alone
    • E. Heintz, T.H. Brodtkorb, and N. Nelson The long-term cost-effectiveness of fetal monitoring during labour: a comparison of cardiotocography complemented with ST analysis versus cardiotocography alone BJOG 115 2008 1676 1687
    • (2008) BJOG , vol.115 , pp. 1676-1687
    • Heintz, E.1    Brodtkorb, T.H.2    Nelson, N.3
  • 56
    • 33744810358 scopus 로고    scopus 로고
    • Comprehensive cost-utility analysis of newborn screening strategies
    • A.E. Carroll, and S.M. Downs Comprehensive cost-utility analysis of newborn screening strategies Pediatrics 117 2006 S287 S295
    • (2006) Pediatrics , vol.117
    • Carroll, A.E.1    Downs, S.M.2
  • 57
    • 42249105678 scopus 로고    scopus 로고
    • Cost-utility analysis of telemedicine and ophthalmoscopy for retinopathy of prematurity management
    • K.M. Jackson, K.E. Scott, and J. Graff Zivin Cost-utility analysis of telemedicine and ophthalmoscopy for retinopathy of prematurity management Arch Ophthalmol 126 2008 493 499
    • (2008) Arch Ophthalmol , vol.126 , pp. 493-499
    • Jackson, K.M.1    Scott, K.E.2    Graff Zivin, J.3
  • 58
    • 38049037976 scopus 로고    scopus 로고
    • Cost and cost-effectiveness of childhood vaccination against rotavirus in France
    • H. Melliez, D. Levybruhl, and P.Y. Boelle Cost and cost-effectiveness of childhood vaccination against rotavirus in France Vaccine 26 2008 706 715
    • (2008) Vaccine , vol.26 , pp. 706-715
    • Melliez, H.1    Levybruhl, D.2    Boelle, P.Y.3
  • 59
    • 67349215723 scopus 로고    scopus 로고
    • Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination
    • E. Shim, and A.P. Galvani Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination Vaccine 27 2009 4025 4030
    • (2009) Vaccine , vol.27 , pp. 4025-4030
    • Shim, E.1    Galvani, A.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.